search
Back to results

rTMS as a Treatment of Visceral Pain Secondary to Malignancy

Primary Purpose

Malignancy

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Real rTMS(20 Hz, 10 trains, inter train interval 30 sc with total pulses 2000, intensity 80% of motor threshold) daily for 10 consecutive days (5 days/week)
Sham rTMS (same parameters but with coil elevated and angled away from the head) every day for 10 consecutive days (5 days/week).
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Malignancy focused on measuring VAS, VDS, HAM-D, Visceral pain, Malignancy, rTMS, Motor cortex, Analgesia, Dynorphin

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All Sexes

Inclusion Criteria:

  • All patients within age group 18-65 years with malignant visceral pain resistant to medical treatment for at least 2 months or associated with significant adverse effect from medication was involved in this study.

Exclusion Criteria:

  • We excluded patients with intracranial metallic devices or with pacemakers or any other device. We also excluded those with extensive myocardial ischemia, unstable angina and those known to have epilepsy.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Sham Comparator

    Active Comparator

    Arm Label

    Sham rTMS

    Real rTMS

    Arm Description

    Sham-rTMS was applied using the same parameters but with the coil elevated and angled away from the head to reproduce some of subjective sensation of rTMS.

    The active group recieved real-rTMS over the motor cortical area corresponding to the hand of painful side. Each train consist of 2000 pulses at 20 Hz and 80% RMT (total duration 10s). The treatment was repeated every day for 5 consecutive days in week for two weeks (the total number of sessions had be given was 10 sessions).

    Outcomes

    Primary Outcome Measures

    Visceral pain improvement
    Reduction of visceral pain in patients with malignancy measured by VAS, VDS.

    Secondary Outcome Measures

    Reduction of depression manifestation
    Measurement of depression by using (HAM-D) scale.

    Full Information

    First Posted
    March 19, 2014
    Last Updated
    March 19, 2014
    Sponsor
    Assiut University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02092805
    Brief Title
    rTMS as a Treatment of Visceral Pain Secondary to Malignancy
    Official Title
    Repetitive Transcranial Magnetic Stimulation in Visceral Pain Secondary to Malignancy
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2014
    Overall Recruitment Status
    Completed
    Study Start Date
    January 2010 (undefined)
    Primary Completion Date
    January 2012 (Actual)
    Study Completion Date
    January 2012 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Assiut University

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to assess the efficacy of rTMS over primary motor cortex in patients suffering from malignant visceral pain. Thirty four patients were included in the study. They are divided randomly into 2 groups using closed envelop as real rTMS group and sham group. Real rTMS over the hand area of motor cortex (20 Hz, 10 trains with inter train interval 30 second with total pulses 2000, intensity 80% of motor threshold) every day for ten consecutive days (5 days/week) and the coil elevated and angled away from the head as sham stimulation. Patients were evaluated by verbal descriptor scale (VDS), visual analog scale (VAS), and Hamilton rating scale for depression (HAM-D) at the baseline, after 1st, 5th, 10th session, 15 day and 1 month after end of sessions. Serum human dynorphin (Dyn) level was measured at baseline, 5th and 10th session.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Malignancy
    Keywords
    VAS, VDS, HAM-D, Visceral pain, Malignancy, rTMS, Motor cortex, Analgesia, Dynorphin

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    34 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Sham rTMS
    Arm Type
    Sham Comparator
    Arm Description
    Sham-rTMS was applied using the same parameters but with the coil elevated and angled away from the head to reproduce some of subjective sensation of rTMS.
    Arm Title
    Real rTMS
    Arm Type
    Active Comparator
    Arm Description
    The active group recieved real-rTMS over the motor cortical area corresponding to the hand of painful side. Each train consist of 2000 pulses at 20 Hz and 80% RMT (total duration 10s). The treatment was repeated every day for 5 consecutive days in week for two weeks (the total number of sessions had be given was 10 sessions).
    Intervention Type
    Procedure
    Intervention Name(s)
    Real rTMS(20 Hz, 10 trains, inter train interval 30 sc with total pulses 2000, intensity 80% of motor threshold) daily for 10 consecutive days (5 days/week)
    Intervention Type
    Procedure
    Intervention Name(s)
    Sham rTMS (same parameters but with coil elevated and angled away from the head) every day for 10 consecutive days (5 days/week).
    Primary Outcome Measure Information:
    Title
    Visceral pain improvement
    Description
    Reduction of visceral pain in patients with malignancy measured by VAS, VDS.
    Time Frame
    one month
    Secondary Outcome Measure Information:
    Title
    Reduction of depression manifestation
    Description
    Measurement of depression by using (HAM-D) scale.
    Time Frame
    one month

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Eligibility Criteria
    Inclusion Criteria: All patients within age group 18-65 years with malignant visceral pain resistant to medical treatment for at least 2 months or associated with significant adverse effect from medication was involved in this study. Exclusion Criteria: We excluded patients with intracranial metallic devices or with pacemakers or any other device. We also excluded those with extensive myocardial ischemia, unstable angina and those known to have epilepsy.

    12. IPD Sharing Statement

    Learn more about this trial

    rTMS as a Treatment of Visceral Pain Secondary to Malignancy

    We'll reach out to this number within 24 hrs